04 08 EU PRE OPEN
EU indices positive this morning | TA focus on FLSmidth & Co
EUROPE ADVANCE/DECLINE
86% of STOXX 600 constituents traded higher yesterday.
43% of the shares trade above their 20D MA vs 28% Friday (below the 20D moving average).
48% of the shares trade above their 200D MA vs 44% Friday (below the 20D moving average).
The Euro Stoxx 50 Volatility index eased 0.91pt to 25.76, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: Financial Services, Industrial
3mths relative low: Telecom.
Europe Best 3 sectors
automobiles & parts, media, construction & materials
Europe worst 3 sectors
real estate, food & beverage, telecommunications
INTEREST RATE
The 10yr Bund yield rose 2bps to -0.52% (below its 20D MA). The 2yr-10yr yield spread rose 1bp to -17bps (above its 20D MA).
ECONOMIC DATA
FR 07:45: Jun Budget Balance, exp.: E-117.9B
EC 10:00: Jun PPI YoY, exp.: -5%
EC 10:00: Jun PPI MoM, exp.: -0.6%
MORNING TRADING
In Asian trading hours, major currencies rebounded against the U.S. dollar. EUR/USD climbed higher nearing 1.1770, GBP/USD was at elevated levels around 1.3075. USD/JPY managed to stay above 106.00. AUD/USD advanced to levels above 0.7130. As expected, Australia's central bank kept its key interest rate unchanged at 0.25%. Official data showed that Australia's June Retail Sales grew 2.7% on month (+2.4% expected) and Exports increased 3% (+4% expected).
Spot gold was little changed at $1,973 an ounce.
#UK - IRELAND#
BP, oil major, announced 2Q results: "Underlying replacement cost loss for the quarter was 6.7 billion dollars, compared with a profit of 2.8 billion dollars for the same period a year earlier. The result was driven primarily by non-cash Upstream exploration write-offs - 6.5 billion dollars after tax (...) combined with the impact of lower oil and gas prices and very weak refining margins, reduced oil and gas production and much lower demand for fuels and lubricants. Oil trading delivered an exceptionally strong result. (...) A dividend of 5.25 cents per share was announced for the quarter, compared to 10.5 cents per share for the previous quarter."
#GERMANY#
Bayer, a German healthcare giant, said it swung to a 2Q net loss of 9.55 billion euros from a net income of 404 million euros in the prior-year period, citing net special charges of 12.51 billion euros. 2Q EBITDA before special items increased 5.6% on year to 2.88 billion euros on sales of 10.05 billion euros, up 2.5% on a currency- and portfolio-adjusted basis. The Company lowered its forecast on full-year EBITDA before special items to 12.1 billion euros from 12.3-12.6 billion euros previously and that on Core earnings per share to 6.70-6.90 euros from 7.00-7.20 euros.
Hugo Boss, a German premium-apparel company, announced that it swung to a 2Q net loss of 186 million euros from a net income of 52 million euros in the prior-year period on sales of 275 million euros, down 59% on year. The Company said: "Retail sales trends during the second quarter have shown a sequential improvement month by month. This positive trend has also continued so far in Q3, as HUGO BOSS has recorded further improvements in its global retail operations during the month of July."
Fraport, the operator of Frankfurt airport, posted a 1H net loss of 231 million euros, compared with a net income of 165 million euros in the prior-year period on revenue of 911 million euros, down 49% on year. The Company pointed out: "Frankfurt Airport's passenger traffic plummeted by 94.4% year-on-year in the April-to-June 2020 period, while falling by a total of 63.8% during the entire first half."
Infineon Technologies, a semiconductors maker, reported that it swung to a 3Q net loss of 128 million euros from a net income of 224 million euros in the prior-year period.
#BENELUX#
DSM, a Dutch nutrition and health company, reported that 1H net income fell to 270 million euros from 401 million euros in the prior-year period. 1H Adjusted EBITDA eased 4.3% on year to 825 million euros on sales of 4.53 billion euros, slightly lower than 4.57 billion euros a year earlier.
#SWITZERLAND#
Novartis, a Swiss maker of pharmaceutical products, reported positive results from a Phase 2 trial of Kymriah (tisagenlecleucel) in patients with relapsed or refractory follicular lymphoma.
#DENMARK#
FLSmidth & Co, a machinery firm, reported that 2Q EBITA decreased 73% on year to 131 million Danish Krone on revenue of 3.85 billion Danish Krone, down 30%. The Company said: "The clear majority of the revenue decline was attributable to COVID-19, but the change was also a result of a lower backlog entering the year."
From a weekly point of view, the stock remains within a bearish channel since June 2018. Below 214.7 krone, targets are set at 170 Krone and 134.30 krone in extension.
Source: GAIN Capital, TradingView
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.
City Index is a trading name of StoneX Financial Pty Ltd.
The material provided herein is general in nature and does not take into account your objectives, financial situation or needs.
While every care has been taken in preparing this material, we do not provide any representation or warranty (express or implied) with respect to its completeness or accuracy. This is not an invitation or an offer to invest nor is it a recommendation to buy or sell investments.
StoneX recommends you to seek independent financial and legal advice before making any financial investment decision. Trading CFDs and FX on margin carries a higher level of risk, and may not be suitable for all investors. The possibility exists that you could lose more than your initial investment further CFD investors do not own or have any rights to the underlying assets.
It is important you consider our Financial Services Guide and Product Disclosure Statement (PDS) available at www.cityindex.com/en-au/terms-and-policies/, before deciding to acquire or hold our products. As a part of our market risk management, we may take the opposite side of your trade. Our Target Market Determination (TMD) is also available at www.cityindex.com/en-au/terms-and-policies/.
StoneX Financial Pty Ltd, Suite 28.01, 264 George Street, Sydney, NSW 2000 (ACN 141 774 727, AFSL 345646) is the CFD issuer and our products are traded off exchange.
© City Index 2024